Elevated levels of HMGB1 have been reported for numerous cancers, including CRC, and higher levels of HMGB1 has been show to positively correlate with tumour invasion and metastasis (both distant and lymph-node), and reduced survival for CRC patients [22, 23]. This evidence concerns the gene HMGB1 and cancer.